{
    "2020-12-26": [
        [
            {
                "time": "2020-12-26",
                "original_text": "【浙商医药|周报】CXO龙头新高下的思考：空间、趋势和供需 -- 医药行业周报20201226",
                "features": {
                    "keywords": [
                        "CXO",
                        "龙头",
                        "新高",
                        "医药行业"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "香港通过紧急立法使用新冠疫苗 专家称复星新冠疫苗有望最早抵港",
                "features": {
                    "keywords": [
                        "新冠疫苗",
                        "紧急立法",
                        "复星",
                        "香港"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "“医药一哥”股价创上市以来的新高，市值突破6300亿大关",
                "features": {
                    "keywords": [
                        "医药一哥",
                        "股价新高",
                        "市值突破"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "mRNA新冠疫苗获批带动需求提升 多间机构看好复星医药（02196）",
                "features": {
                    "keywords": [
                        "mRNA",
                        "新冠疫苗",
                        "需求提升",
                        "复星医药"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康弘药业：“擦”亮业绩护航定增",
                "features": {
                    "keywords": [
                        "康弘药业",
                        "业绩",
                        "定增"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医保谈判结果未出，恒瑞医药股价新高，“医药股一哥”稳了？",
                "features": {
                    "keywords": [
                        "医保谈判",
                        "恒瑞医药",
                        "股价新高",
                        "医药股一哥"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}